| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |